FollowMyHealth Patient Portal

Marin H. Kollef, MD, FACP, FCCP

Professor, Medicine
Division of Pulmonary and Critical Care Medicine
Director, Medical Intensive Care Unit, Barnes-Jewish Hospital
Director, Respiratory Care Services, Barnes-Jewish Hospital

Specialty Areas

Pulmonary Disease
Critical Care Medicine

Board Certifications

Pulmonary Disease
Internal Medicine
Critical Care Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Referral Information

Professional Consultation Only

Areas of Clinical Interest

Critical care medicine, pneumonia, emphysema,

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Barnes-Jewish Hospital

1 Barnes-Jewish Hospital Plaza
St. Louis, MO 63110

Education

Education

Fellowship: Fred Hutchinson Cancer Institute, Seattle, Washington; Bone Marrow Transplant Critical Care Service 1988
Fellowship: Pulmonary Disease and Critical Care, Madigan Army Medical Center, Tacoma, Washington 1988
Residency: Internal Medicine, Madigan Army Medical Center, Tacoma, Washington 1986
Medical Degree: University Of Rochester, Rochester, New York 1983

Publication & Research

Publication & Research

Analgosedation practices and the impact of sedation depth on clinical outcomes among patients requiring mechanical ventilation in the emergency department: a cohort study.
Stephens RJ, Ablordeppey E, Drewry AM, Palmer C, Wessman BT, Mohr NM, Roberts BW, Liang SY, Kollef MH, Fuller BM
Chest. 2017 Jun 20; pii: S0012-3692(17)31076-0. doi: 10.1016/j.chest.2017.05.041.

PMID:
    28645462
    [PubMed - as supplied by publisher]
Related citations


Performance of a Modern Glucose Meter in ICU and General Hospital Inpatients: 3 Years of Real-World Paired Meter and Central Laboratory Results.
Zhang R, Isakow W, Kollef MH, Scott MG
Crit Care Med. 2017 Jun 21; doi: 10.1097/CCM.0000000000002572.

PMID:
    28640025
    [PubMed - as supplied by publisher]
Related citations


Ventilator-Associated Pneumonia: The Role of Emerging Diagnostic Technologies.
Kollef MH, Burnham CD
Semin Respir Crit Care Med. 2017 Jun; 38(3)253-263. doi: 10.1055/s-0037-1599224.

PMID:
    28578550
    [PubMed - in process]
Related citations


The author replies.
Kollef MH
Crit Care Med. 2017 Jun; 45(6)e630-e631. doi: 10.1097/CCM.0000000000002345.

PMID:
    28509759
    [PubMed - in process]
Related citations


Partial pressure of arterial carbon dioxide and survival to hospital discharge among patients requiring acute mechanical ventilation: A cohort study.
Fuller BM, Mohr NM, Drewry AM, Ferguson IT, Trzeciak S, Kollef MH, Roberts BW
J Crit Care. 2017 Apr 26; 4129-35. doi: 10.1016/j.jcrc.2017.04.033.

PMID:
    28472700
    [PubMed - as supplied by publisher]
Related citations


Recommendations for aerosolized antibiotics in ventilator-associated pneumonia and ventilator-associated tracheobronchitis: too little and too late?
Kollef MH, Micek ST
Clin Microbiol Infect. 2017 Apr 8; pii: S1198-743X(17)30201-X. doi: 10.1016/j.cmi.2017.04.001.

PMID:
    28400338
    [PubMed - as supplied by publisher]
Related citations


Lung-Protective Ventilation Initiated in the Emergency Department (LOV-ED): A Quasi-Experimental, Before-After Trial.
Fuller BM, Ferguson IT, Mohr NM, Drewry AM, Palmer C, Wessman BT, Ablordeppey E, Keeperman J, Stephens RJ, Briscoe CC, Kolomiets AA, Hotchkiss RS, Kollef MH
Ann Emerg Med. 2017 Mar 1; pii: S0196-0644(17)30028-8. doi: 10.1016/j.annemergmed.2017.01.013.

PMID:
    28259481
    [PubMed - as supplied by publisher]
Related citations


The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.
Kollef MH, Bassetti M, Francois B, Burnham J, Dimopoulos G, Garnacho-Montero J, Lipman J, Luyt CE, Nicolau DP, Postma MJ, Torres A, Welte T, Wunderink RG
Intensive Care Med. 2017 Feb 4; doi: 10.1007/s00134-017-4682-7.

PMID:
    28160023
    [PubMed - as supplied by publisher]
Related citations


Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia: Conventional Antibiotics Won't Cut It.
Burnham JP, Kollef MH
Clin Infect Dis. 2017 Apr 15; 64(8)1089-1091. doi: 10.1093/cid/cix060.

PMID:
    28158521
    [PubMed - in process]
Related citations


A Quasi-Experimental, Before-After Trial Examining the Impact of an Emergency Department Mechanical Ventilator Protocol on Clinical Outcomes and Lung-Protective Ventilation in Acute Respiratory Distress Syndrome.
Fuller BM, Ferguson IT, Mohr NM, Drewry AM, Palmer C, Wessman BT, Ablordeppey E, Keeperman J, Stephens RJ, Briscoe CC, Kolomiets AA, Hotchkiss RS, Kollef MH
Crit Care Med. 2017 Apr; 45(4)645-652. doi: 10.1097/CCM.0000000000002268.

PMID:
    28157140
    [PubMed - indexed for MEDLINE]
Related citations


Rapid MRSA PCR on respiratory specimens from ventilated patients with suspected pneumonia: a tool to facilitate antimicrobial stewardship.
Trevino SE, Pence MA, Marschall J, Kollef MH, Babcock HM, Burnham CD
Eur J Clin Microbiol Infect Dis. 2017 May; 36(5)879-885. doi: 10.1007/s10096-016-2876-5.

PMID:
    28004323
    [PubMed - indexed for MEDLINE]
Related citations


Viruses are prevalent in non-ventilated hospital-acquired pneumonia.
Shorr AF, Zilberberg MD, Micek ST, Kollef MH
Respir Med. 2017 Jan; 12276-80. doi: 10.1016/j.rmed.2016.11.023.

PMID:
    27993295
    [PubMed - in process]
Related citations


COUNTERPOINT: Should Inhaled Antibiotic Therapy Be Used Routinely for the Treatment of Bacterial Lower Respiratory Tract Infections in the ICU Setting? No.
Kollef MH
Chest. 2017 Apr; 151(4)740-743. doi: 10.1016/j.chest.2016.11.007.

PMID:
    27916619
    [PubMed - in process]
Related citations


Rebuttal From Dr Kollef.
Kollef MH
Chest. 2017 Apr; 151(4)744-745. doi: 10.1016/j.chest.2016.11.005.

PMID:
    27916617
    [PubMed - in process]
Related citations


A Respiratory Therapist Disease Management Program for Subjects Hospitalized With COPD.
Silver PC, Kollef MH, Clinkscale D, Watts P, Kidder R, Eads B, Bennett D, Lora C, Quartaro M
Respir Care. 2017 Jan; 62(1)1-9. doi: 10.4187/respcare.05030.

PMID:
    27899531
    [PubMed - in process]
Related citations


A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial.
Kollef MH, Ricard JD, Roux D, Francois B, Ischaki E, Rozgonyi Z, Boulain T, Ivanyi Z, János G, Garot D, Koura F, Zakynthinos E, Dimopoulos G, Torres A, Danker W, Montgomery AB
Chest. 2017 Jun; 151(6)1239-1246. doi: 10.1016/j.chest.2016.11.026.

PMID:
    27890714
    [PubMed - in process]
Related citations


A targeted educational intervention to reduce ventilator-associated complications.
Nolley EP, Trevino SE, Babcock HM, Kollef MH
Am J Infect Control. 2016 Nov 1; 44(11)1406-1407. doi: 10.1016/j.ajic.2016.03.052.

PMID:
    27238942
    [PubMed - in process]
Related citations


Real-time automated clinical deterioration alerts predict thirty-day hospital readmission.
Micek ST, Samant M, Bailey T, Chen Y, Lu C, Heard K, Kollef MH
J Hosp Med. 2016 Nov; 11(11)768-772. doi: 10.1002/jhm.2617.

PMID:
    27256009
    [PubMed - in process]
Related citations


A Randomized Trial of Palliative Care Discussions Linked to an Automated Early Warning System Alert.
Picker D, Dans M, Heard K, Bailey T, Chen Y, Lu C, Kollef MH
Crit Care Med. 2017 Feb; 45(2)234-240. doi: 10.1097/CCM.0000000000002068.

PMID:
    27768613
    [PubMed - indexed for MEDLINE]
Related citations


Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review.
Burnham JP, Kirby JP, Kollef MH
Intensive Care Med. 2016 Dec; 42(12)1899-1911.

PMID:
    27699456
    [PubMed - in process]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following earned financial interests during calendar year 2016.

Company Name: Merck

Royalties:

Equity: No

Consulting/Advisory Board: $1,000 - $10,000

Speaker Fees: $25,001 - $50,000

Reporting Date: May 01, 2017


Company Name: Allergan/Cubist

Royalties:

Equity: No

Consulting/Advisory Board: $1,000 - $10,000

Speaker Fees: $25,001 - $50,000

Reporting Date: May 01, 2017


Company Name: Arsanis

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $10,001 - $25,000

Reporting Date: May 01, 2017